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Genetic mouse model (39,XO) for human Turner Syndrome (45,XO) harboring either
a single maternally inherited (Xm) or paternally inherited (Xp) chromosome show a
pronounced difference in survival rate at term. However, a detailed comparison of XmO
and XpO placentas to explain this difference is lacking. We aimed to investigate the
morphological and molecular differences between XmO and XpO termmouse placentas.
We observed that XpO placentas at term contained a significantly larger area of glycogen
cells (GCs) in their outer zone, compared to XmO, XX, and XY placentas. In addition, the
outer zone of XpO placentas showed higher expression levels of lactate dehydrogenase
(Ldha) than XmO, XX, and XY placentas, suggestive of increased anaerobic glycolysis.
In the labyrinth, we detected significantly lower expression level of trophectoderm
(TE)-marker keratin 19 (Krt19) in XpO placentas than in XX placentas. The expression
of other TE-markers was comparable as well as the area of TE-derived cells between XO
and wild-type labyrinths. XpO placentas exhibited specific defects in the amount of GCs
and glucose metabolism in the outer zone, suggestive of increased anaerobic glycolysis,
as a consequence of having inherited a single Xp chromosome. In conclusion, the XpO
genotype results in amore severe placental phenotype at term, with distinct abnormalities
regarding glucose metabolism in the outer zone.
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INTRODUCTION
Turner Syndrome is the most common sex chromosome disorder affecting 1 in 2,000 live births.
It is caused by the loss of genetic material from one of the sex chromosomes and the retained
single X chromosome can be inherited either from the mother (Xm) or the father (Xp) (Saenger,
1996). In humans, 99% of the XO fetuses are lost during pregnancy (Cockwell et al., 1991; Ranke
and Saenger, 2001). By contrast, in mice, 90% of embryos with a single Xm survive to term, whereas
40% of embryos with a single Xp are resorbed due to severe placental abnormalities (Burgoyne et al.,
1983a,b; Hunt, 1991). This suggests that the transcription of a single Xm or Xp in mouse placentas
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is not equivalent and influences development differently,
reflecting either a different genome-wide epigenetic landscape
between Xp and Xm or the existence of certain paternally
imprinted X-linked genes in the mouse placenta.
X chromosome inactivation (XCI) is better understood in
mice than in humans (Payer and Lee, 2008, 2014; Okamoto
et al., 2011; Deng et al., 2014; Petropoulos et al., 2016) due
to the existence of well-studied genetic sub-strains of mice. In
mice, in female (XX) late blastocysts, the trophectoderm (TE),
and primitive endoderm (PE) show imprinted XCI (with an
obligatory active Xm) and the epiblast (EPI) shows random
XCI (in each cell either the Xm or Xp is active; Payer and
Lee, 2008; Silva et al., 2009; Okamoto et al., 2011). In the
placenta, the TE-derived cells [trophoblast giant cells (TGCs),
spongiotrophoblasts and glycogen cells (GCs) in the outer zone;
mononuclear trophoblast cells and syncytiotrophoblast cells in
the labyrinth] maintain imprinted XCI (active Xm). By contrast,
the chorionic plate and the embryonic endothelial cells of the
labyrinth are derived from EPI, therefore showing random XCI.
In humans, there may not be imprinted XCI in the placenta
(de Mello et al., 2010; Penaherrera et al., 2012; Hamada et al.,
2016). By the end of the first trimester, the placental volume of
XO and control placenta seemed comparable (Wegrzyn et al.,
2005); and the birth weight of XmO and XpO new-born babies
was similar (Mathur et al., 1991). Nevertheless, there is a higher
incidence of XpO human fetuses lost during pregnancy (Jacobs
et al., 1989) and the percentage of patients retaining the XmO is
60%–80% (Monroy et al., 2002; Uematsu et al., 2002; Sagi et al.,
2007; Ko et al., 2010; Álvarez-Nava et al., 2013).
The placenta is a crucial organ during mammalian
development, ensuring the selective and directional transport of
gases, nutrients and waste products between the maternal blood
and the embryonic blood (Jansson, 2016). In mice, the GCs may
serve as a potential additional energy source, due to their high
glycogen content and sensitivity to glucagon signaling (Coan
et al., 2006). The placenta is a highly regulative organ that adapts
constantly to the maternal environment, for example oxygen
tension and hypoxia (Adelman et al., 2000; Higgins et al., 2016),
availability of nutrients or calorie restriction (Ganguly et al.,
2012) and exposure to maternal hormones (Fowden et al., 2009;
Dimasuay et al., 2016) to sustain optimal embryonic growth
throughout pregnancy.
Interestingly, (epi)genetic abnormalities that affect placental
development trigger an adaptive response in the placenta to
suppress the decreased efficiency to support embryonic growth
(Hemberger, 2002; Lefebvre, 2012; Sandovici et al., 2012; Himes
et al., 2013). In the case of XO embryos, embryonic day (E)8.5
XpO embryos had been shown to have small ectoplacental cones
(Jamieson et al., 1998). However, by E14, XpO placentas had
caught up in size and some showed a larger outer zone (Zechner
et al., 1997). At E18.5, XpO placentas were significantly heavier
than XX controls (Burgoyne et al., 1983b). But in a later study,
XmO, XpO, and XY placentas were found heavier than XX
placentas (Ishikawa et al., 2003).
To date, a detailed comparison of XmO and XpO term
placentas, in particular the TE-derived part of the placenta, is
missing. Here, we show that E18.5 XpO placentas exhibited
significantly larger area occupied by GCs in outer zone when
compared to XmO, XX, and XY placentas. Moreover, the
expression of Ldha, coding for the enzyme that converts lactate
to pyruvate through anaerobic glycolysis, was significantly
higher in outer zone of XpO placentas than the XmO, XX,
and XY placentas, suggesting increased anaerobic glycolysis
and underlying possible defects in oxygen availability in XpO
placentas. In conclusion, the XpO genotype results in a more
severe placental phenotype at term, with distinct abnormalities
regarding glucose metabolism in the outer zone.
MATERIALS AND METHODS
Mice and Genotyping
All animal tissues used in this work were a generous gift from
P. Burgoyne in accordance with the United Kingdom Animals
Scientific Procedures Act 1986 and approved by the local ethical
committee of the National Institute ofMedical Research, London.
MF1 mice bearing XX and XY embryos were from XX × XY
crossings. XmO and XpO mice were generated as previously
described (Ishikawa et al., 2003). Briefly, XmO animals were
produced by crossing XX females with XYOmales, and identified
by visual detection of female genitalia; the XYO males were
generated by crossing XPafO females with XY∗ males. The
XpO animals were generated by crossing In(X)Paf/X females
with XY males. All females [In(X)/X, XXPaf, and XpO] were
karyotyped with trypsin-Giemsa banding using fresh liver to
identify the XpO embryos (with 39 chromosomes as opposed to
40 chromosomes).
Placenta Collection and Histology
From a total of 12 litters, E18.5 embryos were isolated
in phosphate buffer saline (PBS) and separated into males
and females by morphology and genotyped as above. The
placentas were dissected into quarters and some quarters
were collected for RNA isolation after removal of the outer
zone (Jz, TGCs, and decidua), whereas others were fixed
in 4% paraformaldehyde (PFA, Merck, Darmstadt, Germany)
at 4◦C overnight (o/n), washed in PBS and dehydrated
through increasing concentrations of ethanol and finally xylene,
embedded in paraffin and serially sectioned (5µm) in the sagittal
plane using a microtome (Leica RM2055, Nussloch, Germany)
in the medial-to-lateral direction (N = 3 XX, N = 3 XY, N = 5
XmO, N = 4 XpO).
Prior to Periodic acid-Shiff (PAS) staining, sections were
deparaffinised in xylene, rehydrated through a series of ethanol
solutions and incubated 30 min at 56◦C in pre-heated 1%
periodic acid (Sigma-Aldrich, St. Louis, USA), rinsed in
water, immersed in Schiff ’s reagent (Klinipath, Duiven, The
Netherlands) 30 min at room temperature (RT), rinsed in
water and counterstained with Mayer’s haematoxylin (Merck,
Darmstadt, Germany). Congo red, Masson’s trichrome and
Hematoxylin-eosin staining were performed using standard
histological procedures. Stained sections were washed in water,
dehydrated through a series of ethanol, xylene, and mounted in
Entellan (Merck, Darmstadt, Germany).
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Quantitative Reverse-Transcription
Polymerase Chain Reaction (QPCR)
QPCR was performed on placental quarters after removal of
the outer zone and analyzed as described (de Melo Bernardo
et al., 2015); or on RNA material isolated from 5x paraffin
sections of the outer zone using RecoverAll total nucleic
acid isolation kit (AM1975, Ambion, Carlsbad, CA, USA)
following the manufacturer’s protocol. For normalization, the
11Ct method was used with the reference genes Ubc and
B2m, stably expressed in mouse placenta (Solano et al.,
2016). All individual placentas were analyzed in technical
triplicates. The fold change in expression was calculated relative
to the XX1 placenta. Briefly, the average 1Ct value from
the technical triplicates of the XX1 (Ave 1Ct XX1) was
calculated. Next, we subtracted Ave 1Ct XX1 from each 1Ct
(11Ct) and the relative fold change [2−(11Ct)] calculated.
The fold change of each of the triplicate values per placenta
was then averaged (mean) and the standard deviation was
calculated. The primers used are listed in Supplementary
Table 1.
Immunofluorescence
Paraffin sections were deparaffinised and used for
immunofluorescence as previously described (Heeren et al.,
2015). Primary antibodies used were rabbit anti-KRT19 (or
keratin 19) (1:250; ab52625, Abcam, Cambridge, UK) and
rat anti-EMCN (or endomucin) (1:150; sc-65495, Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Afterwards, sections
were washed in 0.05% Tween-20/PBS, treated with 0.3%
Sudan Black B (Edward Gurr Ltd, London, UK) in 70%
ethanol for 5 min to eliminate background autofluorescence
from red blood cells (Romijn et al., 1999) and incubated
with secondary antibodies diluted in blocking solution for
1 h at RT. Secondary antibodies were Alexa Fluor 488 goat
anti-rabbit (1:500; A-11034, Life Technologies, Eugene,
OR, USA) and Alexa Fluor 555 goat anti-rat (1:500; A-
21434, Life Technologies, Eugene, OR, USA). Nuclei were
stained with 4′,6-diamidino-2-phenylindole (DAPI) (Vector
Laboratories, Peterborough, UK) and sections were mounted
in Prolong Gold anti-fade reagent (Life technologies, Eugene,
OR, USA). Slides used for isotype controls were treated as
above using rabbit immunoglobulin fraction (1:250; X0903,
Dako, Heverlee, Belgium) and rat IgG2a (1:150, MAB006,
R&D Systems, Minneapolis, MN, USA) instead of the primary
antibodies.
Imaging and Quantification
Bright-field images were taken on an Olympus AX70 microscope
(Olympus, Zoeterwoude, Netherlands) equipped with a digital
camera (Olympus XC50, Tokyo, Japan). Fluorescence images
were acquired on a Leica DMRA fluorescence microscope (Leica,
Wetzlar, Germany) with a CoolSnap HQ2 camera (Photometrics,
Tucson, USA) or a Leica AF6000 fluorescence microscope with
a Hamamatsu EM-CCD C9100 camera (Leica Microsystems,
Wetzlar, Germany). Quantification was performed in ImageJ 1.48
(http://imagej.nih.gov/ij).
Statistical Analysis
The statistical analyses of the proportion of glycogen cells area in
the outer zone of the placentas, the percentage of fetal vascular
space, the area occupied by TE-derived cells in the labyrinth
and differential gene expression per genotype were performed
using one-way ANOVAwith the Tukey-HSD applied for post-hoc
testing, using statistical software package SPSS 20.0 (SPSS Inc.,
Chicago, IL, USA). P < 0.05 was considered significant.
RESULTS
At Term, XpO Placentas Showed Larger
Area Occupied by GCs in the Outer Zone
We investigated the placental morphology of the four genotypes
(N = 3 XX, N = 3 XY, N = 5 XmO, N = 3 XpO) at E18.5 using
PAS-staining. This allowed us to distinguish the outer zone from
the labyrinth (Figure 1A). We observed the presence of a broader
outer zone in the lateral part of XmO (N = 2 in 5, 40%) and XpO
(N = 3 in 3, 100%) placentas (Figure 1A). To quantify the area
occupied by GCs in the outer zone, the ratio of the area occupied
by GCs in the outer zone was calculated on individual placental
sections (n = 3–5 medial sections per placenta, containing a
visible connection to the umbilical cord; Figures 1B,C). The XpO
placentas contained a significantly larger area occupied by GCs
in the outer zone when compared to XX, XY, and XmO placentas
(P= 0.004, 0.008, and 0.045, respectively, Figure 1C). In contrast,
the area occupied by GCs in the outer zone of XmO placentas was
comparable to that of XX and XY placentas (Figure 1C).
At Term, XpO Placentas Showed Increased
Ldha Expression in the Outer Zone
The larger area of GCs in outer zone of XpO placentas led
us to investigate defects in gene expression related to glucagon
signaling and glucose metabolism (Figure 2A) in the outer zone.
The expression level of glucagon receptor (Gcgr) as well as of
glucose transporter Slc2a1, which mediate passive glucose uptake
in cells (Zhao and Keating, 2007) was similar between XmO,
XpO, and XX placentas (Figure 2B, Supplementary Table 2).
Two X-linked genes, G6pdx and Pgk1, encode essential
enzymes in the conversion of glucose to pyruvate (Semenza et al.,
1994; Tuttle et al., 2000). In the outer zone, G6pdx showed
significantly lower expression in both XmO and XpO placentas
compared to the XX placentas (XmO vs. XX: P = 0.028; XpO
vs. XX: P = 0.007; Figure 2B, Supplementary Table 2). However,
expression of Pgk1 was significantly higher in XpO placentas
than in XmO placentas (P = 0.009, Figure 2B, Supplementary
Table 2).
Under normal oxygen supply (aerobic glycolysis), pyruvate is
catabolized into acetyl-CoA to be used in the tricarboxylic acid
(TCA) cycle to produce energy efficiently (Figure 2A). One of
the enzymes of the TCA cycle, encoded by X-linked gene Idh3g,
showed similar expression between XO and wild-type placentas
(Figure 2B, Supplementary Table 2). However, if oxygen supply
is low, pyruvate is metabolized to lactate (anaerobic glycolysis).
In anaerobic glycolysis, the key enzyme that converts pyruvate
into lactate is encoded by the Ldha gene. The expression levels
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FIGURE 1 | XpO placentas have a larger area occupied by glycogen cells in the outer zone. (A) Representative PAS-stained medial placental sections of the different
genotypes (XX, XY, XmO, XpO). (B) From the images acquired by microscopy, the outer zone of the placenta is digitally selected, then converted to black-and-white
on Image J to provide the total area of the outer zone. From the selected outer zone of the placenta, the dark PAS-stained glycogen cells (GCs) are identified digitally
(red cells) by selecting a threshold on Image J. The percentage of the GCs in the outer zone of each placenta section is obtained by using the ratio of the area of GCs
­/total area of the outer zone ¬ . (C) Graph depicting the percentage (%) area of outer zone occupied by GCs in the different genotypes (XX, XY, XmO, XpO).
Significant P-values between XpO placentas and the other genotypes are indicated by *P < 0.05 and **P < 0.01.
of Ldha in the outer zone of XpO placentas were significantly
higher than in the other placentas (XpO vs. XX: P = 0.007;
XpO vs. XY: P = 0.015; XpO vs. XmO: P < 0.001; Figure 2B,
Supplementary Table 2), suggesting higher levels of anaerobic
respiration specifically in the outer zone of the XpO placentas,
where a higher incidence of GCs was found.
The Labyrinths of XO and Wild-Type
Placentas Were Comparable
Next, we determined the relative expression of TE markers
[keratin 19 (Krt19), syncytin b (Synb), glial cells missing
homolog 1 (Gcm1)] and endothelial markers [endoglin (Eng),
platelet/endothelial cell adhesion molecule 1 (Pecam1)] in the
labyrinth of the four types of placentas.
The expression levels of TE-marker Krt19 in the labyrinth of
XpO placenta were significantly lower than that in XX placenta
(P = 0.024, Figure 2C, Supplementary Table 2). However, the
TE-markers Synb and Gcm1 were similarly expressed in the four
types of placentas (Figure 2C, Supplementary Table 2). There was
also no difference in the expression of endothelial-markers Eng
and Pecam1 in the labyrinth (Figure 2C, Supplementary Table
2). Together, the data suggests that the labyrinth of XO placentas
may be similar to wild-type placentas.
To further confirm that, we quantified the area occupied
by (EMCN-positive) fetal capillaries and (KRT19-positive) TE-
derived cells in the labyrinth (n = 3–5 sections per individual
placenta; N = 3 XX, N = 3 XY, N = 5 XmO, N = 4 XpO;
Figure 3). For the quantification, single channel images of the
labyrinth zone from medial placental sections immunostained
for anti-EMCN (red) and anti-KRT19 (green), and DAPI (details
shown in Figures 3B,D,E) were used. The area of the fetal
vasculature (Figure 3B), considered the area occupied by the
EMCN-positive fetal capillaries, was similar between XO and
wild-type labyrinths (Figure 3C, left panel). Moreover, the
vascular density, calculated as the number of fetal capillaries per
image, was also comparable between XO andwild-type labyrinths
(Figure 3C, right panel).
To quantify the area of occupied by TE-derived cells, the
nuclei area (DAPI-positive) was merged with the KRT19-positive
cytoplasmic staining of the TE derived cells. However, to exclude
the nuclear area of the fetal vasculature, we subtracted the fetal
vascular area (Figures 3B,D,E). In this way, we obtained the area
occupied solely by TE-derived cells (cytoplasm and nuclei). We
concluded that the area occupied by TE-derived cells in labyrinth
was similar between XO and wild-type placentas (Figure 3E).
At Term, XpO Placentas Showed
Decreased Xlr4b/4c in the Labyrinth Zone
The X-linkedXlr3b has previously been identified as differentially
expressed in XmO and XpO brains, but not in the placentas
(Davies et al., 2005). In addition to Xlr3b, Xlr4b/4c were also
reported to be differentially expressed between XmO and XpO
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FIGURE 2 | Expression of genes related to glucose metabolism in the outer zone and expression of genes related to TE and vasculature in the labyrinth. (A) Scheme
of glucose metabolism cascade, with the genes analyzed in blue. (B) Relative expression of the depicted genes in the outer zone of XX, XY, XmO, XpO placentas.
Each bar represents mean ± standard deviation of technical triplicates of a different individual placenta. P-values were calculated between the different
genotype-groups using one-way ANOVA with the Tukey-HSD. Significant P-values between genotypes are indicated by *P < 0.05, **P < 0.01, and ***P < 0.001.
(C) Relative expression of the depicted genes in the labyrinth of XX, XY, XmO, XpO placentas. Each bar represents mean ± standard deviation of technical triplicates
of a different individual placenta. Significant P-value between XX and XpO is indicated by *P < 0.05.
brains, but at least Xlr4c not in placentas (Raefski and O’Neill,
2005). However, whole placentas were used for analysis and
a possible regional regulation could have been missed. We
therefore investigated the expression of Xlr3b and Xlr4b/4c
separately in outer zone and labyrinth zone of term placenta.
We did not observe significantly differential expression of
Xlr3b andXlr4b/4c in the XpO and XmO outer zones (Figure 4A,
Supplementary Table 2), even though XpO outer zones had
significantly lower Xlr3b than XY outer zones (P = 0.030;
Figure 4A, Supplementary Table 2). In the labyrinth zone, the
expression levels of Xlr3b were comparable between genotypes
(Figure 4B, Supplementary Table 2), but surprisingly XpO
labyrinth zone had significantly lower expression levels of
Xlr4b/4c than the other placentas (XpO vs. XX: P = 0.006;
XpO vs. XY: P < 0.001; XpO vs. XmO: P = 0.003; Figure 4B,
Supplementary Table 2).
At Term, XmO Placentas Contained Higher
Incidence of Fibrin Nodules in the Maternal
Arterial Sinuses Adjacent to the Chorionic
Plate
Interestingly, the XmO placentas contained small nodules,
partially occluding some maternal arterial sinuses proximal of
the chorionic plate (black arrow in Figure 1A). After Congo
red, Masson’s trichrome and Hematoxylin-eosin staining, we
concluded that those were fibrin deposits (Figure 5A).
To quantify the incidence of fibrin nodules in the different
placentas (N = 3 XX, N = 3 XY, N = 5 XmO, N = 4 XpO),
we manually counted the number of fibrin nodules present in
medial placental sections. All XmO placentas contained fibrin
deposits in most sections analyzed, whereas the nodules were
not observed in most of the other placentas (XmO vs. XX:
P = 0.0007; XmO vs. XY: P= 0.0007; XmO vs. XpO: P = 0.0019;
Figure 5B). On average, per section one or two nodules were
observed (Figures 5A,C).
DISCUSSION
The lack of a second sex chromosome in XO mouse embryos
leads to the development of smaller trophectoderm ectoplacental
cones and, in some cases, pregnancy loss (Burgoyne et al.,
1983b; Hunt, 1991; Thornhill and Burgoyne, 1993; Jamieson
et al., 1998; Ishikawa et al., 2003). Our study on XO placental
abnormalities in mice shows that inheriting the single X
chromosome from the paternal or maternal side leads to different
placental phenotypes: E18.5 XpO placentas contained a larger
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FIGURE 3 | XO placentas show comparable fetal vascular area and TE-derived cell area in the labyrinth. (A) Representative medial placental sections from the different
genotypes (XX, XY, XmO, XpO) immunostained for KRT19 and EMCN show the organization of the fetal vasculature and maternal blood space in the labyrinth. (B) To
quantify the fetal vascular area and density, single channel images for EMCN-positive fetal capillaries are filled with black area ¬  and either the number of vessels
counted (density of fetal vessels in that area) or the percentage of fetal vascular area is quantified (sum of the area of EMCN-positive blood vessels/total area of the
image × 100). (C) Graph depicting the percentage (%) of area occupied by fetal vasculature and the density of EMCN-positive fetal blood vessels in the different
genotypes analyzed (XX, XY, XmO, XpO). (D) To calculate the percentage of area occupied by TE-derived cells, the single channel images for DAPI ­ and KRT19 ®
are converted to black-and-white, added digitally and finally from that area (­+®) the fetal capillary area is subtracted (­+®−¬) (sum of the resulting black area/total
area of the image × 100). (E) Graph depicts the percentage (%) of area occupied by TE-derived cells in the different genotypes analyzed (XX, XY, XmO, XpO).
area of GCs in the outer zone with a possible consequent
increase in anaerobic glycolysis and/or oxygen availability.
This does not seem to be the case in XmO placentas. By
contrast, XmO placentas show increased incidence of small fibrin
nodules in maternal arterial sinuses proximal of the chorionic
plate.
The placenta is sensitive to defects in epigenetic regulation,
such as regulation of imprinted genes and imprinted X
inactivation (Hemberger, 2002; Lefebvre, 2012; Himes et al.,
2013). As such, it is not surprising that many imprinted and
X-linked genes are expressed in the placenta and regulate
metabolism and growth (Hemberger, 2002; Lefebvre, 2012;
Sandovici et al., 2012). The higher incidence of GCs in
the outer zone of XpO placentas may be such an adaptive
response to placental insufficiency. Studies in mice show
that XpO fetuses have a higher risk of being lost during
pregnancy, whereas XmO fetuses generally have a better
chance of surviving to term (Hunt, 1991; Jamieson et al.,
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FIGURE 4 | Xlr genes expression in the outer zone and labyrinth zone of term
placentas. (A,B) Relative expression of Xlr3b and Xlr4b/4c in the outer zone
(A) and labyrinth zone (B) of XX, XY, XmO, XpO placentas. Each bar
represents mean ± standard deviation of technical triplicates of a single
placenta. Significant P-values between genotypes are indicated by *P < 0.05,
**P < 0.01, and ***P < 0.001.
1998). In XX fetuses, the Xp is preferentially inactivated
in the TE-derived tissues (Harper et al., 1982). Thus, in
both females and males, it is the Xm that is active in
TE-derived tissues during placental development. Epigenetic
differences between Xp and Xm, including genome-wide
differences in chromatin condensation or the existence of X-
linked paternally imprinted genes in the placenta, could explain
why XpO embryos have a higher risk of being lost during
pregnancy.
Alternatively, as a smaller trophectoderm ectoplacental cone
in XO embryos is often associated with a delay in embryonic
development (Thornhill and Burgoyne, 1993; Jamieson et al.,
1998; Ishikawa et al., 2003), the alteration observed in GCs
in outer zone of XpO placentas could reflect a general small
delay in development instead of an (active) adaptive response.
Interestingly, it has been shown that both the number of GCs
and the volume of the junctional zone increases during gestation,
peaks at E16.5, followed by reduction until birth (Coan et al.,
2004, 2006). Therefore, if the physiological regression of GCs in
XpO placentas was delayed, this would result in relatively more
GCs and increased size of the outer zone at E18.5 compared to
wild-type placentas.
Abnormal GC numbers, related to impaired glucose transport
and glycogen metabolism in placenta (Redline et al., 1993;
Sibley et al., 2004), have been reported in several mutant
mouse placentas, including that of X-linked and imprinted
genes, and usually result in runting. Opposite phenotypes
regarding GCs numbers can still develop in mouse mutants
showing a normal placenta at E10.5. As the XpO phenotype,
maternally inherited defects in X-linked Evx1 also showed higher
numbers of GCs, spongiotrophoblasts and secondary TGCs
by E14.5 and the mutant pups were smaller at birth (Li and
Behringer, 1998). By contrast, Cited2 KO and the imprinted
(paternally-expressed) Igf2 KO mice show severe reduction of
numbers of GCs, spongiotrophoblasts and secondary TGCs at
E12.5–13.5 (Lopez et al., 1996; Withington et al., 2006), but
this also resulted in reduced weight at birth (Sibley et al.,
2004); whereas the imprinted (maternally-expressed) Cdkn1c
(or p57Kip2) KO showed placentomegaly, with larger labyrinth
zone and excess of spongiotrophoblasts, but normal number of
GCs and TGCs and no difference in the weight of embryos
(Takahashi et al., 2000).
The detected significantly higher expression of Ldha in outer
zone of XpO placentas indicates a switch from aerobic to
anaerobic glycolysis in outer zone of XpO placentas. Ldha
expression is reported to be increased in human primary
placental trophoblast cells under hypoxic conditions (Kay
et al., 2007). Interestingly, transcriptomics analysis between
XX and XO human fibroblasts revealed differences in glucose
metabolism (Rajpathak et al., 2014), but the parental origin of
the X chromosome was unclear. Moreover, women with Turner
syndrome are characterized by increased size of type IIa muscle
fibers in addition to impaired glucose tolerance and insulin
resistance, indicating diminished oxygen and substrate supply for
metabolic processes (Gravholt et al., 2001). It is also reported that
Turner syndrome women have increased anaerobic glycolysis
and lactic acid production during exercise, compared to a control
group (Wells et al., 2013).
It is unclear whether Xlr factors are directly involved in
glucose metabolism, but they could impact on cell differentiation
in the outer zone toward GC cells. We observed similar
expression of Xlr3b and Xlr4b/4c in XpO and XmO outer zones
suggesting that these genes are not involved in the production
of GCs and are not imprinted in the (TE-derived) outer zone.
However, the biological significance of the specific decrease in
Xlr4b/4c in XpO labyrinth remains to be investigated. If this
decrease is not due to imprinting in TE-derived labyrinth cells
(mononuclear trophoblast and syncytiotrophoblast cells), then
perhaps Xlr4b/c could be imprinted and silenced on the Xp
in the EPI-derived endothelial cells of the labyrinth, in line
with the reported imprint in the brain (Raefski and O’Neill,
2005). This could explain the 40% reduction in expression
observed.
Small fibrin nodules, most probably from maternal blood-
clots, were observed in the maternal sinus of all XmO placentas,
but not in most of the other placentas. Interestingly, TE-derived
cells at the fetal-maternal interface in both mouse and human
exhibit endothelial-like properties (endovascular extravillous
trophoblast cells and syncytiotrophoblast cells in humans;
syncytiotrophoblast cells in mice) and seem to be involved in the
regulation of coagulation during pregnancy (Sood et al., 2006).
Fibrin deposits are occasionally described in the labyrinth and
spongiotrophoblast area of mouse placentas (Vogt et al., 1996;
Redecha et al., 2009); and in the perivillous space, associated with
local syncytial denudation, in human placentas (Nelson et al.,
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FIGURE 5 | Identifications and quantification of fibrin deposits in term placentas. (A) Representative medial XmO placenta sections with Congo red, Masson’s
trichrome and Hematoxylin-Eosin staining. The dashed boxes in top panels are shown as magnification in bottom panels. Black arrows point to fibrin deposits.
(B) Graph depicting the percentage (%) of placental sections with fibrin nodules per histological section (n) in different genotypes. Significant P-values between XmO
placentas and the other genotypes are indicated by **P < 0.01 and ***P < 0.001. (C) Graph depicting the percentage (%) of placental sections with different
abundance of fibrin nodules per histological section (n in B) in different genotypes.
1990; Khan et al., 2011). Excessive fibrin deposits at the fetal-
maternal interface early during development, such as in Procr
(or Epcr) KO embryos results in severe placental thrombosis and
lethality at E10.5 (Gu et al., 2002); whereas inWnt2 KO embryos
showed fibrin deposits between E14 and E18 with maternal blood
accumulation in the labyrinth zone, resulting in 50% viability and
smaller pups at birth (Monkley et al., 1996). The fibrin deposits
in XmO placentas indicate excessive activation of the coagulation
cascade in the maternal circulation, but this obstruction was not
as severe as in Wnt2 KO mice and, as such, does not seem to be
pathological.
In conclusion, mouse embryos with a single Xp have a lower
chance than XmO embryos to survive to term due to placental
insufficiency. Here, we show that XmO and XpO term placentas
differ significantly in the amount of GCs in the outer zone and
that XpO placentas may have shifted toward anaerobic glycolysis.
This shift in glucose metabolism does not seem to be a direct
consequence of altered expression of X-linked genes involved in
this metabolism (although Pgk1 expression differs between XmO
and XpO outer zones), but rather a consequence of an altered
cellular composition of the XpO outer zone (large GCs area)
due to placental adaptive response earlier during development.
Our findings highlight the need to investigate glucosemetabolism
in the placenta of human Turner patients, which may
provide individual potential therapeutic strategies for Turner
Syndrome.
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